Group items tagged

Blind Girl Can See Thanks to Umbilical Cord-Based Adult Stem Cell Treatment London, England (LifeNews.com) -- Born two years ago with severe eye problems, Dakota Clarke could not even see well enough to recognize her own mother and father. But now the parents of the little girl, who is registered blind, say she can make out their faces for the first time after pioneering stem cell treatment. The couple gave up work to raise well over $40,000 to fly their daughter to China for the treatment, which remains at the experimental level in Britain -- because the nation has been too preoccupied with embryonic stem cells and human cloning. They returned home this week convinced that Dakota can now see colors, lights and objects around her as a result. They hope further therapy will give her a lifetime of sight. "It's nothing short of a miracle for us," said Mr Clarke, a former engineer. "She can see the world for the first time." In Dakota's case, cells were administered intravenously through her hairline and reportedly traveled towards her optic nerve, repairing the damaged area. The stem cells came from umbilical cords donated by Chinese mothers. Despite the obvious success, some doctors are talking down the results simply because the treatments aren't approved in England. Pro-life advocates say the results are yet another showing of how adult stem cells outpace their embryonic cousins both ethically and when used in treatments.

TUESDAY, April 14 (HealthDay News) -- A particular type of stem cell transplantation using the patient's own cells led to short-term freedom from insulin injections in 20 of 23 patients newly diagnosed with type 1 diabetes participating in an experimental protocol in Brazil. One patient even managed to go four years without needing outside sources of insulin, although the average was 31 months, said the authors of a report in the April 15 issue of the Journal of the American Medical Association, a themed issue on diabetes. The patients also kept their blood sugar under control, which is key to preventing complications from diabetes. And, the authors stated, increased C-peptide levels indicated that the pancreas' beta cells were alive and well.

"SCIENTISTS have shown that a new class of cancer drugs called PARP inhibitors, currently being tested in clinical trials to treat breast and ovarian cancer could have dramatic results when used to treat other solid tumours, according to work presented at the NCRI Cancer Conference today. "